Catalyst Wire Dossier Catalyst Wire Dossier

BIC/F/TAF

bictegravir/emtricitabine/tenofovir alafenamide · Gilead Sciences
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BIC/F/TAF, covering 2024-02-08 to 2025-09-26. Get the full timeline:

Most recent: Clinical Trial Update: Retrospective Review of DTG/3TC Versus BIC/F/TAF Across a Multi Clinic Infectious Disease Organization in Southeast United States

See pricing